SARS-CoV Spike Produkte
(SARS-Coronavirus Spike Protein (SARS-CoV S))
Kategorien
antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.
Ausgewählte SARS-CoV Spike Kategorien
SARS-CoV Spike Antikörper
High quality antibodies with extensive validation data.
SARS-CoV Spike Proteine
Proteins for various applications incl. WB, ELISA, IF etc.
Empfohlene SARS-CoV Spike Antikörper
Produkt
Reaktivität
Applikation
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
SARS Coronavirus (SARS-CoV)
Applikation
WB
Validierungen
- (1)
- (2)
Kat. Nr.
ABIN199984
Menge
100 μg
Datenblatt
Datenblatt
Reaktivität
SARS Coronavirus (SARS-CoV)
Applikation
ELISA, WB, IF, IC
Validierungen
- (5)
- (3)
Kat. Nr.
ABIN2452119
Menge
50 μg
Datenblatt
Datenblatt
Reaktivität
SARS Coronavirus (SARS-CoV)
Applikation
WB
Validierungen
- (6)
- (1)
Kat. Nr.
ABIN1882129
Menge
400 μL
Datenblatt
Datenblatt
Empfohlene SARS-CoV Spike Proteine
Produkt
Reaktivität
Source
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
SARS Coronavirus (SARS-CoV)
Source
HEK-293 Cells
Validierungen
- (4)
Kat. Nr.
ABIN7275548
Menge
100 μg
Datenblatt
Datenblatt
Reaktivität
SARS Coronavirus (SARS-CoV)
Source
HEK-293 Cells
Validierungen
- (1)
- (3)
Kat. Nr.
ABIN6952627
Menge
100 μg
Datenblatt
Datenblatt
Reaktivität
SARS Coronavirus (SARS-CoV)
Source
HEK-293 Cells
Validierungen
- (2)
Kat. Nr.
ABIN7275549
Menge
100 μg
Datenblatt
Datenblatt
Neueste Publikationen zu unseren SARS-CoV Spike Produkten
: "Small form factor flow virometer for SARS-CoV-2." in: , Vol. 13, Issue 3, pp. 1609-1619, (2022) (PubMed).: "Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry." in: Nature communications, Vol. 12, Issue 1, pp. 250, (2021) (PubMed).
: "Seroprevalence of anti-SARS-CoV-2 antibodies in a cohort of New York City metro blood donors using multiple SARS-CoV-2 serological assays: Implications for controlling the epidemic and "Reopening"." in: PloS one, Vol. 16, Issue 4, pp. e0250319, (2021) (PubMed).
: "An antigen microarray protocol for COVID-19 serological analysis." in: STAR protocols, Vol. 2, Issue 3, pp. 100815, (2021) (PubMed).
: "A live measles-vectored COVID-19 vaccine induces strong immunity and protection from SARS-CoV-2 challenge in mice and hamsters. ..." in: Nature communications, Vol. 12, Issue 1, pp. 6277, (2021) (PubMed).
: "Low Seroprevalence of SARS-CoV-2 in Rhode Island blood donors during may 2020 as determined using multiple serological assay formats." in: BMC infectious diseases, Vol. 21, Issue 1, pp. 871, (2021) (PubMed).
: "38" in: , Vol. 1363, Issue Nucleic acids research, pp. 28-39, (1991)
: "Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV." in: Nature communications, Vol. 11, Issue 1, pp. 1620, (2020) (PubMed).
: "Evaluate Severe Acute Respiratory Syndrome Coronavirus 2 Infectivity by Pseudoviral Particles." in: Journal of medical virology, (2020) (PubMed).
: "Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with 2019 Novel Coronavirus Disease, United States. ..." in: Emerging infectious diseases, Vol. 26, Issue 6, (2020) (PubMed).
Haben Sie etwas anderes gesucht?
- SARS-CoV S2
- SARS-CoV S1
- SARS-CoV NSP3
- SARS-CoV E2 Glycoprotein
- SARS-Coronavirus Nucleocapsid Protein
- SARS-Coronavirus Nonstructural Protein 8
- SARS-Coronavirus Membrane Protein
- SARS-Coronavirus Envelope Protein
- SARS Associated Spike Mosaic S
- SARNP
- SARM1
- SARDH
- Sarcolemma Associated Protein
- Sarcalumenin
- SAR1B
- SAR1A
- Sar1
- SAPS2
- SAPS1
- SAPCD2
- SARS-CoV-2
- SARS-CoV-2 (CB6 Biosimilar)
- SARS-CoV-2 Envelope
- SARS-CoV-2 Membrane Protein
- SARS-CoV-2 NSP1
- SARS-CoV-2 NSP10
- SARS-CoV-2 NSP12 (RdRP)
- SARS-CoV-2 NSP13
- SARS-CoV-2 NSP14
- SARS-CoV-2 NSP15
- SARS-CoV-2 NSP16
- SARS-CoV-2 NSP2
- SARS-CoV-2 NSP3
- SARS-CoV-2 NSP4
- SARS-CoV-2 NSP5 (3CL-Pro)
- SARS-CoV-2 NSP6
- SARS-CoV-2 NSP7
- SARS-CoV-2 NSP8
- SARS-CoV-2 NSP9
- SARS-CoV-2 Nucleocapsid
Sie sind hier:
